Isoniazid or Moxifloxacin in Rifapentine-based Regimens for Experimental Tuberculosis? - Concepedia

Concepedia

Publication | Open Access

Isoniazid or Moxifloxacin in Rifapentine-based Regimens for Experimental Tuberculosis?

DOI Full Paper Access

65

Citations

12

References

2008

Year

Ian M. Rosenthal, Ming Zhang, Deepak V. Almeida, J Grosset, Eric Nuermberger

American Journal of Respiratory and Critical Care Medicine

Abstract

These results suggest that regimens consisting of isoniazid or moxifloxacin plus rifapentine and pyrazinamide may dramatically shorten the duration of treatment needed to cure human tuberculosis.

References

	Year	Citations
Pharmacokinetics-Pharmacodynamics of Rifampin in an Aerosol Infection Model of Tuberculosis Ramesh Jayaram, Sheshagiri Gaonkar, Parvinder Kaur, Antimicrobial Agents and Chemotherapy	2003	335
Moxifloxacin-containing Regimen Greatly Reduces Time to Culture Conversion in Murine Tuberculosis Eric L. Nuermberger, Tetsuyuki Yoshimatsu, Sandeep Tyagi, American Journal of Respiratory and Critical Care Medicine New DrugPulmonary TuberculosisTuberculosis Control ProgramsAntibioticsMedicine	2003	317
Moxifloxacin-containing Regimens of Reduced Duration Produce a Stable Cure in Murine Tuberculosis Eric Nuermberger, Tetsuyuki Yoshimatsu, Sandeep Tyagi, American Journal of Respiratory and Critical Care Medicine Tuberculosis PreventionImmunologyPharmacotherapyAntimicrobial ChemotherapyDrug Resistance	2004	221
Tuberculosis in Africa — Combating an HIV-Driven Crisis Richard E. Chaisson, Neil Martinson New England Journal of Medicine Tuberculosis PreventionWorst TuberculosisDisease OutbreakHiv-driven CrisisMedical Anthropology	2008	214
Daily Dosing of Rifapentine Cures Tuberculosis in Three Months or Less in the Murine Model Ian M. Rosenthal, Ming Zhang, Kathy N. Williams, PLoS Medicine	2007	211
Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice J Grosset, C. Truffot-Pernot, Christian Lacroix, Antimicrobial Agents and Chemotherapy	1992	146
A Nested Case–Control Study on Treatment-related Risk Factors for Early Relapse of Tuberculosis Kwok Chiu Chang, Chi Chiu Leung, Wing Wai Yew, American Journal of Respiratory and Critical Care Medicine	2004	135
A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis Final report: Results during the 36 months after the end of chemotherapy and beyond British Thoracic Society British Journal of Diseases of the Chest Pulmonary TuberculosisControlled TrialMedicineTuberculosis PreventionMetronomic Therapy	1984	106
Potent Twice-Weekly Rifapentine-containing Regimens in Murine Tuberculosis Ian M. Rosenthal, Kathy N. Williams, Sandeep Tyagi, American Journal of Respiratory and Critical Care Medicine	2006	89
Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in mice V. Lalande, C. Truffot-Pernot, A Paccaly-Moulin, Antimicrobial Agents and Chemotherapy Antibiotic AdjuvantImmunologyPharmacotherapyAntimicrobial ChemotherapyVarious Monotherapies	1993	89

Page 1